hydroflumethiazide has been researched along with propranolol in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Berry, C; Finnerty, FA; Gyftopoulos, A; McKenney, A | 1 |
| Akinkugbe, OO; Carlisle, R; Olatunde, A | 1 |
| Kristensen, BO | 1 |
| Ogola, EN; Orinda, DA; Yonga, GO | 1 |
| Ogola, EN; Yonga, GO | 1 |
1 review(s) available for hydroflumethiazide and propranolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for hydroflumethiazide and propranolol
| Article | Year |
|---|---|
Step 2 regimens in hypertension. An assessment.
Topics: Adult; Aged; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hydroflumethiazide; Hypertension; Male; Methyldopa; Middle Aged; Propranolol; Reserpine | 1979 |
Metabolic effects of propranolol and hydroflumethiazide treatment in Kenyans with mild to moderate essential hypertension.
Topics: Adolescent; Adult; Aged; Drug Monitoring; Female; Humans; Hydroflumethiazide; Hypertension; Kenya; Male; Middle Aged; Propranolol; Prospective Studies; Severity of Illness Index; Single-Blind Method | 1993 |
Comparative study of the efficacy and tolerability of hydroflumethiazide versus propranolol in Africans with mild to moderate hypertension.
Topics: Adult; Aged; Black People; Blood Pressure; Diastole; Female; Humans; Hydroflumethiazide; Hypertension; Kenya; Male; Matched-Pair Analysis; Middle Aged; Propranolol; Severity of Illness Index; Time Factors | 1993 |
7 other study(ies) available for hydroflumethiazide and propranolol
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Beta-adrenergic blockers in the treatment of hypertension--experience with propranolol at Ibadan, Nigeria.
Topics: Adult; Aged; Debrisoquin; Drug Therapy, Combination; Female; Humans; Hydroflumethiazide; Hypertension; Male; Methyldopa; Middle Aged; Nigeria; Propranolol | 1977 |
HDL-cholesterol, triglycerides and vascular complications in essential hypertension.
Topics: Adult; Aged; Cardiovascular Diseases; Cholesterol; Female; Humans; Hydroflumethiazide; Hypertension; Lipoproteins, HDL; Male; Middle Aged; Propranolol; Random Allocation; Triglycerides | 1981 |